Breaking News
October 22, 2018 - Compression Collar May Protect Brain of Female Soccer Players
October 22, 2018 - Technique visualizes neuron communication
October 22, 2018 - Advancement in medical imaging methods for health care
October 22, 2018 - Takeda presents vedolizumab phase 3 VISIBLE 1 trial results for treatment of moderately to severely active ulcerative colitis
October 22, 2018 - Immunotherapy increases survival in some patients with metastatic triple negative breast cancer
October 22, 2018 - Exelixis presents CABOSUN and METEOR trial results in patients with advanced renal cell carcinoma
October 22, 2018 - LYNPARZA Phase III SOLO-1 results show improved outcome for patients with advanced BRCA-mutated ovarian cancer
October 22, 2018 - Brainlab unveils ExacTrac Dynamic at ASTRO meeting in San Antonio, Texas
October 22, 2018 - Not exercising is worse than smoking, diabetes or heart disease finds study
October 22, 2018 - Shorter course of trastuzumab could be an option for women with HER2+ early breast cancer
October 22, 2018 - Map of Mouse Hippocampus Could Be Weapon Against Alzheimer’s
October 22, 2018 - Psychotropic polypharmacy is common in Alzheimer’s disease
October 22, 2018 - Texas A&M and UTA establish Texas Genomics Core Alliance
October 22, 2018 - Analyzing mouse’s potential as animal model of decision-making
October 22, 2018 - Radiotherapy can prolong survival in prostate cancer
October 22, 2018 - A genetic mutation involved in relapse
October 21, 2018 - Report reveals growing impact of cannabis on young people
October 21, 2018 - NSF awards $5 million grant to help scientists magnify societal impact of research
October 21, 2018 - Fertility Rates Down for Each Urbanization Level 2007 to 2017
October 21, 2018 - Genetically engineered 3-D human muscle transplant in a murine model
October 21, 2018 - Moms’ tight work schedules may affect their children’s sleep
October 21, 2018 - AHA: No Direct Link Between Preeclampsia and Cognitive Impairment, Study Finds
October 21, 2018 - Weight loss success linked with active self-control regions of the brain
October 21, 2018 - Scripps researchers successfully test potential new smoking-cessation treatment in rodents
October 21, 2018 - More accurate and less stressful way to measure a baby’s heartbeat
October 21, 2018 - Researchers show better cardiorespiratory fitness leads to longer life
October 21, 2018 - Healthy candies for diabetic patients
October 21, 2018 - Environment impact of microplastics remains unclear
October 21, 2018 - Antibiotics for appendicitis? Surgery often not needed
October 21, 2018 - AHA and AMA recognize more than 800 medical practices, health systems for blood pressure control
October 21, 2018 - Scientists obtain clearest ever image of Ebola virus protein
October 21, 2018 - Study reveals connection between two proteins known to be hyperactive in cancer
October 21, 2018 - Gabapentin Beats Pregabalin for Chronic Sciatica
October 21, 2018 - Cosmetic surgeons offering incomplete information for breast augmentation customers
October 21, 2018 - Chronic sleep disruption in early adult life accelerates AD-related tau pathology
October 21, 2018 - Take 10 for Mindfulness – Drugs.com MedNews
October 21, 2018 - Length of breathing disruption in OSA may be better predictor of mortality risk
October 21, 2018 - ApoE4 gene linked with chronic inflammation increases risk for Alzheimer’s disease
October 21, 2018 - Mother-daughter conflict associated with suicide risk in abused adolescent girls
October 21, 2018 - Scientists molding bacteria into unnatural shapes
October 21, 2018 - High diet quality associated with lower risk of death in colorectal cancer patients
October 21, 2018 - Discharged mental health patients ‘at greater risk of dying’
October 21, 2018 - Research provides insight into neurobiology of aggression and bullying
October 21, 2018 - As billions in tax dollars flow to private Medicaid plans, Who’s minding the store?
October 21, 2018 - Neuroscientists identify brain region that appears to be related to food preference decisions
October 21, 2018 - Deaths related to air pollution in the U.S. decreased by 47% between 1990 and 2010
October 21, 2018 - Study shows correlation between spatial memory and the sense of smell
October 21, 2018 - Increased cardiorespiratory fitness associated with reduced long-term mortality
October 21, 2018 - IU researchers receive $1.55 million from NIH to improve chronic-disease management
October 21, 2018 - Income and wealth affect the mental health of Australians, study shows
October 21, 2018 - Patients with hypertension and psoriasis more often require cardiovascular interventions
October 20, 2018 - Leading hip-hop videos depict use of tobacco and marijuana products, study finds
October 20, 2018 - Dose Range of IV Ketamine for Adjunct Tx of Depression Tested
October 20, 2018 - Infants can distinguish between leaders and bullies, study finds
October 20, 2018 - Mad Cow disease found on Aberdeenshire farm
October 20, 2018 - Study identifies factors associated with prescription opioid misuse among students
October 20, 2018 - Scientists uncover key regulator of mTORC1 in cancer growth
October 20, 2018 - Pounds Regained After Weight-Loss Op Can Tell Your Doc a Lot
October 20, 2018 - Sending parents letters to fight childhood obesity doesn’t work
October 20, 2018 - Supervised aerobic exercise can support major depression treatment
October 20, 2018 - Mindfulness-based program effective for reducing stress in infertile women
October 20, 2018 - Molecule capable of halting and reverting neurodegeneration caused by Parkinson’s disease identified
October 20, 2018 - Midazolam-mediated alterations of PER2 expression may have functional consequences during myocardial ischemia
October 20, 2018 - Sweat bees are ideal for studying the genes underlying social behavior
October 20, 2018 - Weight loss success associated with brain areas involved in self-control
October 20, 2018 - KHN’s ‘What the Health?’ Republicans’ preexisting political problem
October 20, 2018 - Research provides a more complete picture of suffering caused by terrorist attacks
October 20, 2018 - Eradicating Helicobacter pylori infections may be a key treatment for Parkinson’s disease
October 20, 2018 - Breast Cancer as a Dynamic Disease
October 20, 2018 - University of Pittsburgh wins NSF grant for big data research to prevent complications from anesthesia
October 20, 2018 - Skin-to-skin contact may promote attachment between parents and preterm infants
October 20, 2018 - Recommendations Developed to Verify NGT Placement in Children
October 20, 2018 - Weight loss can be boosted fivefold thanks to novel mental imagery technique
October 20, 2018 - Children with autism are more likely to be overweight, obese
October 20, 2018 - Nurses making conscientious objections to ethically-relevant policies lack support
October 20, 2018 - Prion strain diversity may be greater than previously thought
October 20, 2018 - Antidepressant treatment may lead to improvements in sleep quality of patients with depression
October 20, 2018 - Study reports increased risk of death in children with inflammatory bowel disease
October 20, 2018 - Number of Autism Genes Now Tops 100
October 20, 2018 - Total diet replacement programmes are effective for treating obesity
Inexpensive testing spurs cancer patients’ relatives to assess own disease risk | News Center

Inexpensive testing spurs cancer patients’ relatives to assess own disease risk | News Center

image_pdfDownload PDFimage_print

An online initiative offering low-cost genetic testing to relatives of people with genetic mutations that increase their risk of cancer encourages the “cascade” testing that can help to identify healthy people at risk of the disease, according to a new study by researchers at the Stanford University School of Medicine and Color, a health services company that provides genetic testing.

The study of more than 700 people bearing one of 30 cancer-associated mutations found that nearly half of a patient’s first-degree relatives (think mother, father, siblings and children) chose to undergo testing when contacted by a genetic testing laboratory and offered a chance to have their own genes sequenced for about $50 — about one-tenth the standard cost. Furthermore, about 12 percent of those found to have the same mutation as the original patient then went on to invite additional relatives to be tested.

Although not everyone with a cancer-associated mutation will go on to develop the disease, the knowledge that one is a carrier can help people and their doctors make informed health care decisions while they are still healthy. For example, women with BRCA1 or BRCA2 mutations who have a vastly increased risk of developing breast or ovarian cancers may choose to undergo prophylactic mastectomies or have their ovaries removed. Other types of mutations, such as those that increase one’s risk of colon cancer, may indicate the need for increased or more frequent screening.

“We’ve found that this approach has been remarkably successful in overcoming traditional barriers to reaching and testing a patient’s relatives,” said Allison Kurian, MD, associate professor of medicine and of health research and policy at Stanford. “The results have been very striking, as traditional approaches to cascade testing result in only about 30 percent of relatives undergoing testing.”

Kurian shares senior authorship of the research, which was published Sept. 18 in the Journal of the National Cancer Institute, with Alicia Zhou, PhD, who is head of research at Color, based in Burlingame, California. Jennifer Caswell-Jin, MD, instructor of medicine at Stanford, and Anjali Zimmer, PhD, a technical writer from Color, are the lead authors of the study.

Growing interest in genetic tests

Increasingly, newly diagnosed cancer patients are turning to genetic testing in a quest to understand why they’ve developed the disease. The discovery of a disease-associated mutation can help drive treatment decisions and provide clues as to the cancer’s origin. But there’s another important, often overlooked, benefit: The test results can help a patient’s healthy first-degree relatives assess their own genetic risk for cancer. About 50 percent of these relatives could be expected to harbor the same mutation as the patient, even if they haven’t developed cancers themselves.

However, this kind of cascade testing, in which a positive result in a cancer patient triggers waves of genetic testing among the patient’s relatives, remains relatively rare — in part because physicians are often prohibited from directly contacting a patient’s relatives, and people reeling from their own recent diagnosis may not immediately consider the health implications for their loved ones. Testing can also be expensive and is not always covered by insurance.

Because about half of a patient’s first-degree relatives are also likely carriers of the same mutation, cascade testing has significant public health implications for early cancer detection and even prevention.

Kurian and her colleagues wondered if there was an easier way to reach potential carriers. They evaluated the first year of a family testing program in which people found to harbor one of 30 cancer-associated genes were encouraged to provide the testing laboratory with email addresses for their first-degree relatives. The laboratory then contacted the relatives to provide more information via a web portal and invite them to be tested for an out-of-pocket cost of $50.

“One unique thing about this study is that it isn’t focused on any single gene,” Caswell-Jin said. “These participants were carriers of mutations in any of 30 different genes, some of which are very strongly associated with the development of specific cancers. Because about half of a patient’s first-degree relatives are also likely carriers of the same mutation, cascade testing has significant public health implications for early cancer detection and even prevention.”

To conduct the study, the researchers invited carriers of one of 30 cancer-associated mutations, identified by any one of several certified genetic testing laboratories, and their relatives to participate in the family testing program. They reached possible participants through the use of online advertising, notices in physicians’ clinics or at group meetings for families with hereditary cancers.

From September 2016 to September 2017, 1,101 people — 741 people who carried the mutation themselves, and 360 relatives of the carriers — opted to participate in the program. Together, the original participants then invited 2,280 of their relatives to also be tested. Nearly half of those invited underwent testing themselves within the study’s follow-up period.

As expected, about one-half of the tested relatives were also carriers. About 12 percent of these people then used the family testing program to invite additional first-degree relatives to be tested.

“Although this was potentially lower than we might have expected, in many cases it was due to the fact that there were no more first-degree relatives in the family to test,” Caswell-Jin said.

Different mutations identified

Surprisingly, the researchers found that about 5 percent of relatives tested carried cancer-associated mutations that differed from those of their patient relatives.

“These pathogenic mutations were totally unexpected and suggest that this may reflect the prevalence in the general population of known cancer-associated mutations,” Kurian said. “It addresses a long-standing question in the field about what we might find if we routinely tested everyone.”

The researchers emphasize that, regardless of how people are contacted to be tested, it is important to involve a genetic counselor to interpret test results and direct mutation carriers to appropriate health care services.

“This is such an exciting era,” Caswell-Jin said. “We expect the proportion of people undergoing genetic testing for disease-associated mutations will continue to increase. We need to make sure they get the support they need to understand their results, and to encourage additional support and follow-up.”         

“We are very engaged in learning how to most effectively implement genetic testing, particularly in a broad population,” Kurian said. “We are eager to pursue this finding further and to understand how we can improve on this new model of cascade testing.”

Another Stanford author of the study is senior genetic counselor Kerry Kingham. Kurian is a member of the Stanford Cancer Institute.

The research was supported by the BRCA Foundation, the Damon Runyon Cancer Research Foundation and Color.

Kurian has received research funding from Myriad Genetics for an unrelated project.

Stanford’s departments of Medicine and of Health Research and Policy also supported the work.

Tagged with:

About author

Related Articles